Teleflex Inc. stock slips 1.64% and underperforms competitors in weak market session
Updated
Updated · MarketWatch · Apr 29
Teleflex Inc. stock slips 1.64% and underperforms competitors in weak market session
12 articles · Updated · MarketWatch · Apr 29
Teleflex Inc. closed at $133.30 on Wednesday, falling 1.64%, with trading volume at 621,953—well below its 50-day average.
The stock ended 4.56% below its 52-week high of $139.67, reached just a week earlier on April 22.
Major competitors like Johnson & Johnson, Medtronic, and Boston Scientific also declined, as the S&P 500 and Dow Jones both posted losses during the broadly negative session.
Why was Teleflex stock upgraded to 'hold' despite a massive earnings miss and plunging sales?
Can Teleflex's planned asset sales successfully fund its pivot to higher growth amid market turmoil?
Is Teleflex a value trap with its high P/E ratio or a hidden gem based on cash flow?
How will new 2026 FDA and EU regulations affect struggling MedTech firms like Teleflex?
As competitors dominate in AI-driven tech, how can Teleflex innovate to regain market share?
How will the Middle East oil crisis impact the MedTech sector's already strained supply chains?